Literature DB >> 12512504

The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view.

Stylianos Karatzas, Eleni Boutzouka, Kyriaki Venetsanou, Pavlos Myrianthefs, George Fildisis, George Baltopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12512504      PMCID： PMC153443          DOI： 10.1186/cc1837

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  3 in total

Review 1.  Intravenous immunoglobulin for treating sepsis and septic shock.

Authors:  M M Alejandria; M A Lansang; L F Dans; J B Mantaring
Journal:  Cochrane Database Syst Rev       Date:  2001

2.  Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater.

Authors:  L Dominioni; R Dionigi; M Zanello; M Chiaranda; R Dionigi; A Acquarolo; A Ballabio; C Sguotti
Journal:  Arch Surg       Date:  1991-02

3.  The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830].

Authors:  Simru Tugrul; Perihan Ergin Ozcan; Ozkan Akinci; Yalcin Seyhun; Atahan Cagatay; Nahit Cakar; Figen Esen
Journal:  Crit Care       Date:  2002-05-14       Impact factor: 9.097
  3 in total
  7 in total

Review 1.  Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis.

Authors:  Axel Nierhaus; Giorgio Berlot; Detlef Kindgen-Milles; Eckhard Müller; Massimo Girardis
Journal:  Ann Intensive Care       Date:  2020-10-07       Impact factor: 6.925

Review 2.  Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.

Authors:  Marissa M Alejandria; Mary Ann D Lansang; Leonila F Dans; Jacinto Blas Mantaring
Journal:  Cochrane Database Syst Rev       Date:  2013-09-16

3.  Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock.

Authors:  Ilaria Cavazzuti; Giulia Serafini; Stefano Busani; Laura Rinaldi; Emanuela Biagioni; Marta Buoncristiano; Massimo Girardis
Journal:  Intensive Care Med       Date:  2014-09-13       Impact factor: 17.440

Review 4.  Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective.

Authors:  Manu Shankar-Hari; Jo Spencer; William A Sewell; Kathryn M Rowan; Mervyn Singer
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

5.  Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial.

Authors:  Marta O Soares; Nicky J Welton; David A Harrison; Piia Peura; Manu Shankar-Hari; Sheila E Harvey; Jason Madan; Anthony E Ades; Kathryn M Rowan; Stephen J Palmer
Journal:  Crit Care       Date:  2014-12-01       Impact factor: 9.097

6.  The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis.

Authors:  Jie Cui; Xuxia Wei; Haijin Lv; Yuntao Li; Ping Li; Zhen Chen; Genglong Liu
Journal:  Ann Intensive Care       Date:  2019-02-06       Impact factor: 6.925

7.  Adjunctive IgM-enriched immunoglobulin therapy with a personalised dose based on serum IgM-titres versus standard dose in the treatment of septic shock: a randomised controlled trial (IgM-fat trial).

Authors:  Emanuela Biagioni; Martina Tosi; Giorgio Berlot; Giacomo Castiglione; Alberto Corona; Maria Giovanna De Cristofaro; Abele Donati; Paolo Feltracco; Francesco Forfori; Fiorentino Fragranza; Patrizia Murino; Ornella Piazza; Livio Tullo; Giacomo Grasselli; Roberto D'Amico; Massimo Girardis
Journal:  BMJ Open       Date:  2021-02-11       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.